1. Home
  2. ENTG vs BNTX Comparison

ENTG vs BNTX Comparison

Compare ENTG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entegris Inc.

ENTG

Entegris Inc.

N/A

Current Price

$147.38

Market Cap

25.5B

Sector

Industrials

ML Signal

N/A

Logo BioNTech SE

BNTX

BioNTech SE

N/A

Current Price

$85.42

Market Cap

22.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTG
BNTX
Founded
1966
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5B
22.9B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
ENTG
BNTX
Price
$147.38
$85.42
Analyst Decision
Buy
Buy
Analyst Count
15
21
Target Price
★ $189.79
$113.11
AVG Volume (30 Days)
★ 3.6M
975.2K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
★ 0.26%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.24
N/A
Revenue
★ $3,196,600,000.00
N/A
Revenue This Year
$17.03
N/A
Revenue Next Year
$14.97
$0.50
P/E Ratio
$68.15
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$67.97
$79.81
52 Week High
$186.94
$124.00

Technical Indicators

Market Signals
Indicator
ENTG
BNTX
Relative Strength Index (RSI) 50.22 40.36
Support Level $126.69 $79.81
Resistance Level $166.18 $93.48
Average True Range (ATR) 11.52 2.52
MACD 0.60 0.09
Stochastic Oscillator 49.46 18.05

Price Performance

Historical Comparison
ENTG
BNTX

About ENTG Entegris Inc.

Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: